ClinicalTrials.Veeva

Menu

Predictive Factors for Medullary Thyroid Cancer Aggressiveness (MYELO)

A

Aristotle University Of Thessaloniki

Status

Completed

Conditions

Medullary Thyroid Cancer

Treatments

Procedure: Total Thyroidectomy

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This study is a retrospective study trying to find the predictive factors for medullary thyroid aggressiveness in terms of tumor metastasis and patients' survival.

Full description

This study is a retrospective study trying to find the predictive factors for medullary thyroid aggressiveness in terms of tumor metastasis and patients' survival. The predictive factors included in this study are central and lateral compartment lymph node metastases as well as distant metastasis up to 1 year postoperatively, while biochemical predictors (meaning ratios such as lymphocyte to monocyte ratio etc and CEA and calcitonin drop levels) and histological predictors (such as nuclear atypia, amyloid, immunohistochemistry, desmoplasia) are included as secondary outcomes. In this study , patients >18 years old that underwent surgery for medullary thyroid cancer (total thyroidectomy, completion thyroidectomy) +/- central/lateral neck dissection) will be enrolled.

Enrollment

500 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who underwent thyroidectomy for medullary thyroid cancer (total thyroidectomy, completion thyroidectomy) +/- central/lateral neck dissection

Exclusion criteria

  • Age < 18 years

Trial contacts and locations

46

Loading...

Central trial contact

Theodossis Papavramidis, Prof; Angeliki Chorti, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems